Finance

Lists
Why is AVE up 5,26%?
Dive Deeper
AVE:ASX
Avecho Biotechnology Ltd
0,020ย AUD
+5,26%
(+0,0010) 1D
7 แƒแƒฅแƒข, 11:31:28 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AVE...
Open
0,02ย AUD
High
0,02ย AUD
Low
0,02ย AUD
Mkt. cap
73,41ย แƒ›แƒšแƒœ.
Avg. vol.
3,27ย แƒ›แƒšแƒœ.
Volume
66,23ย แƒแƒ—.
52-wk high
0,03ย AUD
52-wk low
0,00ย AUD
EPS
-0,00ย AUD
Shares outstanding
3,86ย แƒ›แƒšแƒ แƒ“.
No. of employees
15
Open
0,02ย AUD
High
0,02ย AUD
Low
0,02ย AUD
Mkt. cap
73,41ย แƒ›แƒšแƒœ.
Avg. vol.
3,27ย แƒ›แƒšแƒœ.
Volume
66,23ย แƒแƒ—.
52-wk high
0,03ย AUD
52-wk low
0,00ย AUD
EPS
-0,00ย AUD
Shares outstanding
3,86ย แƒ›แƒšแƒ แƒ“.
No. of employees
15
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
14 แƒฌแƒฃแƒ—แƒ˜แƒก แƒฌแƒ˜แƒœ
How $950 Million Settlement Will Impact Roivant Sciences Stock (ROIV)
Moomoo
Moomoo
·
54 แƒฌแƒฃแƒ—แƒ˜แƒก แƒฌแƒ˜แƒœ
๐Ÿ† S&P 500 tops 7,800 for first time as tech rally defies surging yields
CNBC
CNBC
·
5 แƒกแƒแƒแƒ—แƒ˜แƒก แƒฌแƒ˜แƒœ
Chart: A look at the S&P 500's remarkable and defiant trip to a new record
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
แƒกแƒ”แƒฅ. 2025
แƒ“แƒ”แƒ™. 2025
แƒ›แƒแƒ . 2026
แƒ˜แƒ•แƒœ. 2026
Revenue
338,85ย แƒแƒ—.
338,85ย แƒแƒ—.
29,80ย แƒแƒ—.
29,80ย แƒแƒ—.
Cost of goods sold
92,11ย แƒแƒ—.
92,11ย แƒแƒ—.
7,76ย แƒแƒ—.
7,76ย แƒแƒ—.
Cost of revenue
92,11ย แƒแƒ—.
92,11ย แƒแƒ—.
7,76ย แƒแƒ—.
7,76ย แƒแƒ—.
Research and development expenses
478,93ย แƒแƒ—.
478,93ย แƒแƒ—.
221,87ย แƒแƒ—.
221,87ย แƒแƒ—.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
441,76ย แƒแƒ—.
441,76ย แƒแƒ—.
737,40ย แƒแƒ—.
737,40ย แƒแƒ—.
Operating expense
920,69ย แƒแƒ—.
920,69ย แƒแƒ—.
959,27ย แƒแƒ—.
959,27ย แƒแƒ—.
Total operating expenses
1,01ย แƒ›แƒšแƒœ.
1,01ย แƒ›แƒšแƒœ.
967,03ย แƒแƒ—.
967,03ย แƒแƒ—.
Operating income
-673,96ย แƒแƒ—.
-673,96ย แƒแƒ—.
-937,23ย แƒแƒ—.
-937,23ย แƒแƒ—.
Other non operating income
-
-
-
-
EBT including unusual items
-870,33ย แƒแƒ—.
-870,33ย แƒแƒ—.
-961,82ย แƒแƒ—.
-961,82ย แƒแƒ—.
EBT excluding unusual items
-870,33ย แƒแƒ—.
-870,33ย แƒแƒ—.
-961,82ย แƒแƒ—.
-961,82ย แƒแƒ—.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-870,33ย แƒแƒ—.
-870,33ย แƒแƒ—.
-961,82ย แƒแƒ—.
-961,82ย แƒแƒ—.
Net profit margin
-256,85%
-256,85%
-3ย 227,46%
-3ย 227,46%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-196,38ย แƒแƒ—.
-196,38ย แƒแƒ—.
-24,59ย แƒแƒ—.
-24,59ย แƒแƒ—.
Net interest expenses
-196,38ย แƒแƒ—.
-196,38ย แƒแƒ—.
-24,59ย แƒแƒ—.
-24,59ย แƒแƒ—.
Depreciation and amortization charges
-
-
-
-
EBITDA
-639,62ย แƒแƒ—.
-639,62ย แƒแƒ—.
-909,80ย แƒแƒ—.
-909,80ย แƒแƒ—.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google แƒแƒžแƒ”แƒ‘แƒ˜